| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |